This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Privacy Policy
- Global Locations -
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, United States
T: +1-845-579-5705
Market Access DMCC
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
Future Market Insights
3rd Floor, 207 Regent Street,
London W1B 3HH
United Kingdom
T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045 India

Bispecific Antibody Market

Market Insights on Bispecific Antibody covering sales outlook, demand forecast & up-to-date key trends

Bispecific Antibody Market: Global Industry Analysis 2015 - 2019 and Opportunity Assessment; 2020 - 2030

Bispecific Antibody Market Overview

The bispecific antibody is used for therapeutic effects by targeting two or more pathways which often lead to the root of the disease. In this, two or more antigen identifying elements are blended into one.

Bispecific antibody generates better results and minimal side effects at low cost treatment. This potential therapeutic effect of bispecific antibody against more than one disease at a time is estimated to grow bispecific antibody market. 

Bispecific antibody covers a wide spectrum of diseases like oncological, inflammatory and autoimmune disorders, rejection of organ transplants, cardiovascular diseases, allergies, ophthalmic problems and infectious diseases.

 According to WHO, the cancer and cardiovascular disorders are the leading causes of death and this unmet need of novel therapies is expected to meet by bispecific antibody therapies.

COVID-19 pandemic is expected to delay in the clinical research and subsequent launch of new therapies in the bispecific antibody market. Declining rate of hospitalization and treatment adoption are expected to impact negatively on bispecific antibody market.

In addition, the supply chain of bispecific antibody market is projected to impact owing to restriction on trading between several countries. Since 2015 when bispecific antibody market was established there has been exponential growth in terms of revenue generation.

With an increase in research and development activities for the bispecific antibody, the leading industry players are investing in the bispecific antibody. A large number of products under clinical trials will lead to the treatment of numerous disorders with a single approach making bispecific antibody market in most demand. 

High acceptance rate among clinicians and patients due to target specific treatment has boomed bispecific antibody market. With an increase in the prevalence of chronic disorders across the globe acts as a driving force for bispecific antibody market.

However, bispecific antibodies are not an exception and have side effects which limit the growth of bispecific antibody market. Blinatumomab drug type is the highest revenue-generating in the bispecific antibody market.

The bispecific antibody market is estimated to grow exponentially in the coming decade. By indication, cancer is projected as a highest revenue generating segment owing to large patient pool.

Amongst the distribution channel, the hospital pharmacies is estimated to generate highest revenue followed by retail pharmacies. Whereas, online pharmacies are expected to have significant growth rate during the forecast period with advancements in digital technology in the bispecific antibody market.

North America dominates the bispecific antibody market owing to high prevalence of chronic diseases and cancer in this region. Europe is the second-lucrative region for bispecific antibody market owing to development and launch of novel bispecific antibody products in this region.

Asia-Pacific bispecific antibody market is expected to increase substantially owing to high patient pool in the region. Latin America and Middle East & Africa bispecific antibody markets are least lucrative due to unfavourable economic conditions and less healthcare expenditure.

Customize this Report

Let us know your requirement to get
100% FREE customization

Some key players contributing in bispecific antibody market are

  • Sonafi S.A.
  • AbbVie Inc.
  • Pfizer Inc. 
  • Johnson & Johnson
  • Portola Pharmaceuticals 
  • Bristol-Myers Squibb
  • Ganymed Pharmaceuticals
  • OncoMed Pharmaceuticals
  • Merck Amgen 
  • Bayer AG 
  • Daiichi Sankyo Company Limited

The research report on bispecific antibody market presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data.

It also contains projections using a suitable set of assumptions and methodologies. The research report on bispecific antibody market provides analysis and information according to market segments such as drug class, route of administration, application, and region.

Sabyasachi Ghosh
Principal Consultant
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

The report covers exhaust analysis on

  • Market Segments
  • Market Dynamics
  • Market Size
  • Supply & Demand
  • Current Trends/Issues/Challenges
  • Competition & Companies involved
  • Technology
  • Value Chain

Regional analysis includes

  • North America (U.S., Canada)
  • Latin America (Mexico, Brazil)
  • Europe (Germany, Italy, France, U.K, Spain, Russia)
  • East Asia (China, Japan, South Korea)
  • South Asia (India, ASEAN)
  • Oceania (Australia, New Zealand)
  • Middle East and Africa (GCC Countries, South Africa, Northern Africa)

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain.

The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Become a MarketNgage Insider

An unified Market Research Subscription Platform, built for today’s disparate research needs.

Bispecific antibody market Segmentation

The global bispecific antibody market is classified based on drug type, indication, distribution channel and region.

By Drug Type

  • Blinatumomab
  • Catumaxomab
  • Duligotumab 

By Indication

  • Cancer
  • Infectious Disease
  • Inflammatory and Autoimmune Disorders
  • CNS Disorders

By Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Drugstores
  • Online Pharmacies

Table of Content


Customize this Report

Let us know your requirement to get
100% FREE customization

List of Tables


Sabyasachi Ghosh
Principal Consultant
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

List of Charts


Need specific information?

Request Customization

Explore Healthcare Insights

View Reports



Antibody Therapy Market

Published : March 2022


Antinuclear Antibody Test Market

Published : January 2020


Antibody Isotyping Kits Market

Published : October 2019


Anti Neurofilament L Antibody Market

Published : August 2019

Google translate

Bispecific Antibody Market